National Health Investors, Inc. (NYSE:NHI) – Analysts at Capital One Financial reduced their Q1 2021 earnings per share estimates for shares of National Health Investors in a research report issued to clients and investors on Thursday, January 21st. Capital One Financial analyst D. Bernstein now expects that the real estate investment trust will earn $1.37 per share for the quarter, down from their prior estimate of $1.38. Capital One Financial also issued estimates for National Health Investors’ Q2 2021 earnings at $1.38 EPS, Q3 2021 earnings at $1.39 EPS, Q4 2021 earnings at $1.39 EPS and FY2021 earnings at $5.53 EPS. National Health Investors (NYSE:NHI) last announced its earnings results on Monday, November 9th. The real estate investment trust reported $0.95 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.43 by ($0.48). The business had revenue of $84.30 million during the quarter, compared to the consensus estimate of $82.87 million. National Health Investors had a net margin of 56.94% and a return on equity of 12.64%. The company’s revenue was up 3.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.42 EPS.
NHI has been the subject of several other research reports. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, January 14th. BMO Capital Markets cut shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 price objective for the company. in a research report on Thursday, January 7th. Mizuho cut shares of National Health Investors from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $56.00 to $55.00 in a research report on Wednesday, January 13th. Berenberg Bank cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, December 2nd. Finally, KeyCorp raised shares of National Health Investors from an “underweight” rating to a “sector weight” rating in a research report on Monday, December 14th. Two research analysts have rated the stock with a sell rating and seven have issued a hold rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $65.63.
Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. Now people are pouring into cryptos like we haven’t seen in years… but don’t do anything until you see this new warning.
Shares of National Health Investors stock opened at $66.79 on Monday. National Health Investors has a 52-week low of $31.37 and a 52-week high of $91.12. The firm has a 50-day moving average of $67.96 and a 200-day moving average of $63.23. The company has a debt-to-equity ratio of 1.02, a quick ratio of 13.13 and a current ratio of 13.13. The stock has a market cap of $2.99 billion, a PE ratio of 15.68 and a beta of 0.88.
Several institutional investors have recently added to or reduced their stakes in NHI. Private Advisor Group LLC acquired a new position in shares of National Health Investors in the second quarter valued at approximately $31,000. Marshall Wace North America L.P. acquired a new position in shares of National Health Investors in the first quarter valued at approximately $31,000. International Assets Investment Management LLC acquired a new position in shares of National Health Investors in the fourth quarter valued at approximately $32,000. Van ECK Associates Corp increased its stake in shares of National Health Investors by 23.5% in the third quarter. Van ECK Associates Corp now owns 1,298 shares of the real estate investment trust’s stock valued at $78,000 after buying an additional 247 shares during the period. Finally, Avantax Advisory Services Inc. acquired a new position in shares of National Health Investors in the third quarter valued at approximately $202,000. 65.72% of the stock is owned by institutional investors.
In other news, Director Robert G. Adams acquired 2,000 shares of the stock in a transaction dated Monday, December 14th. The stock was bought at an average price of $67.75 per share, with a total value of $135,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert G. Adams acquired 1,000 shares of the stock in a transaction dated Tuesday, November 17th. The stock was purchased at an average cost of $66.45 per share, with a total value of $66,450.00. The disclosure for this purchase can be found here. 5.74% of the stock is currently owned by insiders.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 31st will be paid a dividend of $1.102 per share. This represents a $4.41 annualized dividend and a yield of 6.60%. The ex-dividend date of this dividend is Wednesday, December 30th. National Health Investors’s payout ratio is 80.18%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Recommended Story: Why is the conference call important?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
After a year like 2020, many Americans figure that just getting to 2021 was enough. But for many people, the start of a new year still means making resolutions. And while many Americans are still waking up to Groundhog’s Day, there is hope that things will look dramatically different in September than they do right now.
Some of the most popular resolutions include losing weight, exercising more, or taking steps to get our life and/or business more organized. And many pure-play companies lean into these trends and are doing well.
As an alternative to this, you can also invest in companies that are not pure plays but can still benefit from consumers looking to start fresh. Owning these stocks helps you manage your risk. If the trend holds, you can ride the wave. On the other hand, if the wave turns into a ripple, the stocks have other catalysts to get them through.
In this special presentation, we’ll take a look at both of these categories. We’ve got several pure-play companies that let investors buy stocks in companies benefiting from these trends. We’ll also give you a few stocks that fall in the latter category.
These are stocks that you might buy at any time and for many reasons. However, they present excellent buys as the new year begins.